Flovent and Catheterisation cardiac abnormal - a phase IV clinical study of FDA data

Summary:

Catheterisation cardiac abnormal is reported as a side effect among people who take Flovent (fluticasone propionate), especially for people who are female, 60+ old, also take Flonase, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Catheterisation cardiac abnormal when taking Flovent. It is created by eHealthMe based on reports of 44,023 people who have side effects when taking Flovent from the FDA, and is updated regularly.

What is Flovent?

Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.

What is Catheterisation cardiac abnormal?

Catheterisation cardiac abnormal is found to be associated with 539 drugs and 257 conditions by eHealthMe. Check the latest studies of Catheterisation cardiac abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

44,023 people reported to have side effects when taking Flovent.
Among them, 16 people (0.04%) have Catheterisation cardiac abnormal.

Could Flovent cause Catheterisation cardiac abnormal?

Among these 16 people:

What is the gender of people who have Catheterisation cardiac abnormal when taking Flovent? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Catheterisation cardiac abnormal when taking Flovent? *

What are other drugs people take besides Flovent? *

What are other side effects people have besides Catheterisation cardiac abnormal? *

Chest Pain: 6 people, 37.50%
Dyspnea (difficult or laboured breathing): 5 people, 31.25%
Fatigue (feeling of tiredness): 4 people, 25.00%
Dizziness: 3 people, 18.75%
Back Pain: 3 people, 18.75%
Cardiac Failure Congestive: 3 people, 18.75%
Cardiac Disorder: 3 people, 18.75%
Pain: 3 people, 18.75%
Joint Pain: 2 people, 12.50%
Drug Ineffective: 2 people, 12.50%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 18.75%
Transplant Rejection (a transplant material is not worked): 1 person, 6.25%
Herpes Zoster: 1 person, 6.25%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.25%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 6.25%
Blood Pressure Abnormal: 1 person, 6.25%
Bronchial Hyperreactivity: 1 person, 6.25%
Chest Pain: 1 person, 6.25%
Cough: 1 person, 6.25%
Diabetes: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent and have Catheterisation cardiac abnormal?

- Check whether Catheterisation cardiac abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flovent:

Flovent (44,817 reports)

Browse all side effects of Flovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Catheterisation cardiac abnormal:

Catheterisation cardiac abnormal (539 drugs)

Browse all the conditions that are associated with Catheterisation cardiac abnormal:

Catheterisation cardiac abnormal (257 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flovent) and Flovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.